← All trials
NCT05512039
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2023
- Primary completion
- Sep 1, 2026
- Completion date
- Jan 1, 2027
- First posted
- Aug 23, 2022
- Last posted
- Dec 20, 2022
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dartmouth UniversityLead sponsor
- University of PittsburghCollaborator
- Dartmouth UniversityCollaborator
- Dartmouth UniversityOverall official - principal investigator
- Dartmouth UniversityReponsible party - principal investigator
- Kaiser PermanenteCollaborator
- Oregon Health and Science UniversityCollaborator
- Stanford UniversityCollaborator
- University of ConnecticutCollaborator
- University of Texas, GalvestonCollaborator
- University of Alabama, BirminghamCollaborator
- Patient-Centered Outcomes Research InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.